MCK
McKesson Corporation
NYSE: MCK · HEALTHCARE · MEDICAL DISTRIBUTION
$807.85
-0.76% today
Updated 2026-05-04
Market cap
$99.71B
P/E ratio
23.47
P/S ratio
0.25x
EPS (TTM)
$34.68
Dividend yield
0.38%
52W range
$635 – $999
Volume
0.8M
WallStSmart proprietary scores
62
out of 100
Grade: C+
Hold
Investment rating
8.0
Growth
A7.0
Quality
B+4.5
Profitability
C8.0
Valuation
A4/9
Piotroski F-Score
Moderate
5.2
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$990.87
+22.66%
12-Month target
$885.45
+9.61%
Intrinsic (DCF)
$2,632.66
Margin of safety
+63.79%
3 Strong Buy10 Buy4 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 5.22 — safe zone
+ Free cash flow $1.12B — positive
+ Revenue growth 11.40% QoQ
+ 63.79% below intrinsic value
+ Debt/equity -6.64x — low leverage
Risks
- Thin margins at 1.09%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $263.97B | $276.71B | $308.95B | $359.05B | $397.96B | $412.8B |
| Net income | $1.11B | $3.56B | $3.00B | $3.29B | $1.19B | — |
| EPS | — | — | — | — | $34.68 | $39.41 |
| Free cash flow | $3.90B | $4.60B | $3.63B | $5.23B | $1.12B | — |
| Profit margin | 0.42% | 1.29% | 0.97% | 0.92% | 1.09% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-02 | LAU, MICHELE | Sale | 2,725 | $990.00 |
| 2026-02-19 | MARTINEZ, MARIA | Sale | 349 | $939.87 |
| 2026-02-17 | SMITH, LEANN B | Sale | 190 | $945.00 |
Peer comparison
Smart narrative
McKesson Corporation trades at $807.85. representing a P/E of 23.47x trailing earnings. Our Smart Value Score of 62/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 5.22, it sits in the safe zone. TTM revenue stands at $397.96B. with profit margins at 1.09%. Our DCF model estimates intrinsic value at $2,632.66.
Frequently asked questions
What is McKesson Corporation's stock price?
McKesson Corporation (MCK) trades at $807.85.
Is McKesson Corporation overvalued?
Smart Value Score 62/100 (Grade C+, Hold). DCF value $2,632.66.
What is the price target of McKesson Corporation (MCK)?
The analyst target price is $990.87, representing +22.7% upside from the current price of $807.85.
What is the intrinsic value of McKesson Corporation (MCK)?
Based on our DCF model, intrinsic value is $2,632.66, a +63.8% margin of safety versus $807.85.
What is the future stock price of MCK by 2030?
Our research-backed model estimates McKesson Corporation could reach $55,621.21 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is McKesson Corporation's revenue?
TTM revenue is $397.96B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
5.22 — safe zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL DISTRIBUTION
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.25x
ROE—
Beta0.42
50D MA$893.57
200D MA$812.76
Shares out0.12B
Float0.12B
Short ratio—
Avg volume0.8M
Performance
1 week-1.80%
1 month-5.71%
3 months-1.72%
YTD-1.52%
1 year—
3 years—
5 years—